Skip to main content

Table 2 Patient characteristics and intervention details

From: Substitution of exudative trace element losses in burned children

Patient

Age (years)

Weight (kg)/height (cm)

Body surface area (m2)

PRISM

Burned surface %TBSA

Plasma albumin on D1, D5, D10 D20 (g/l)

Length of mechanical ventilation (days)

Length of ICU stay (days)

LOS (days)

Percentage of adult intravenous dose and duration

Daily dose

Daily dose per kilogram

1

8.5

20/110

0.78

4

Total 53%

Surgical 21%

21/29/26/32

2

22

54

47%, 15 days

Cu 2.6 mg

Se 177 μg

Zn 27 mg

Cu 0.13 mg

Se 8.9 μg

Zn 1.4 mg

2

3

13/98

0.59

1

Total 14%

Surgical 3.5%

27/31/32/-

11

12

23

21%, 7 days

Cu 0.9 mg

Se 82 μg

Zn 14 mg

Cu 0.07 mg

Se 6.3 μg

Zn 1.0 mg

3

12

63/165

1.69

7

Total 45%

Surgical 45%

27/31/28/20

3

27

39

100%, 13 days +

10 days Intestamin*

Cu 3.0 mg

Se 624 μg

Zn 65 mg

Cu 0.05 mg

Se 9.9 μg

Zn 1.0 mg

4

15

60/173

1.69

6

Total 40%

Surgical 20%

29/24/19/24

6

25

36

100%, 14 days +

10 days Intestamin*

Cu 2.47 mg

Se 553 μg

Zn 60 mg

Cu 0.04 mg

Se 9.2 μg

Zn 1.0 mg

  1. Mean age was 12 years and mean percentage of total body surface area burned was 38%. The daily delivered trace element dose is the sum of all intakes, including micronutrient supplements by intravenous and enteral routes (the trace elements in the feeding solutions were minimal and are not included). *Patients received the intravenous supplements for x days, with Intestamin being delivered by the enteral route for 10 days from admission in both teenagers in addition to the intravenous supplement. D, day; LOS, length of hospital stay; PRISM, pediatric risk of mortality; TBSA, total body surface area.